Skip to main content

Practice Tips

  • Ateb announces it tested 4 med sync QIIs on behalf of PQA

     
    RALEIGH, N.C. — Pharmacy technology solutions company Ateb on Tuesday announced that it was one of two companies selected to test four medication synchronization quality improvement indicators (QIIs) on behalf of the Pharmacy Quality Alliance (PQA). 
     

  • AJMC review: Formulary exclusions tend toward neutral, positive patient impacts

    PLAINSBORO, N.J. — A new review of several studies on the impact of drug exclusion from pharmacy benefits managers’s formularies has found that in most cases, these efforts to control costs work without negatively affecting patients. 
     

  • Fred’s makes naloxone available prescription-free in 5 states

    MEMPHIS, Tenn. — Fred’s Pharmacy announced Wednesday that it was joining the ranks of drug chains making overdose reversal medication naloxone available without a prescription. The company has partnered with prescribers in Alabama, Kentucky, Mississippi, North Carolina and Tennessee to make it possible for patients to obtain naloxone without having to first see a doctor. 
     

  • Convenience predominant factor in where to get flu shot, CVS survey finds

    WOONSOCKET, R.I. - A new survey from CVS Health released Tuesday found that more than one-third (34%) of U.S. adults who have ever received the flu shot determine where to get vaccinated based on convenience. Specific convenience factors that would make Americans more likely to have themselves and their families vaccinated against the flu include having the vaccine readily available without an appointment (28%) and being able to get the entire family vaccinated at one place/time (20%).

  • Study: Drug cost estimates trend higher than actual sales

    BEVERLY HILLS — Cost estimates put out before the launch of new drugs can often overestimate their impact on healthcare spending, according to a new study from research consultancy the Partnership for Health Analytics Research. 
     

  • FDA approves new Dysport indication

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Ipsen Biopharmaceuticals’ Dysport (abobotulinumtoxinA), the company announced Monday. The drug can now be used to treat lower limb spasticity in pediatric patients ages 2 years and older. 
     

  • From adherence to patient support, best practices shine at Cardinal Health RBC 2016

    The best practices shared over the course of Cardinal Health RBC 2016 have one thing in common: a focus on patient needs that leads to improved patient health and a more robust business. From expanded clinical services to offerings tailored to caregivers, all of the pharmacies touted as exemplars of independent pharmacy were able to grow their business by providing the best care possible to their patients.

  • The Truth About Pharmacy Compliance. New Report Tells All

    Learn how to easily spot phony prescriptions and save your pharmacists from costly federal fines up to $25,000 each. This 2016 report on pharmacy compliance trends from IMS Health/HDS is a real eye opener. 

X
This ad will auto-close in 10 seconds